4//SEC Filing
McDonough John 4
Accession 0000899243-20-000995
CIK 0001492674other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 6:14 PM ET
Size
13.7 KB
Accession
0000899243-20-000995
Insider Transaction Report
Form 4
McDonough John
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2020-01-08+16,666→ 470,285 total - Exercise/Conversion
Common Stock
2020-01-08+100,000→ 570,285 total - Exercise/Conversion
Restricted Stock Units
2020-01-08−16,666→ 0 total→ Common Stock (16,666 underlying) - Disposition to Issuer
Performance Restricted Stock Units
2020-01-08−326,087→ 0 total→ Common Stock (326,087 underlying) - Exercise/Conversion
Restricted Stock Units
2020-01-08−100,000→ 0 total→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 5,399 shares acquired under the Issuer's employee stock purchase plan on May 15, 2019.
- [F3]On March 15, 2018, the reporting person was granted Performance Restricted Stock Units that vest in the form of common stock based upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three year performance period. On January 8, 2020, the reporting person incurred a termination of service and forfeited the remaining unvested RSU's subject to this grant.
- [F4]Pursuant to the terms of that certain Employment Agreement by and between the reporting person and Issuer, dated March 4, 2008, as amended by that certain First Amendment to Employment Agreement, dated July 7, 2014 and that certain Second Amendment to Employment Agreement, dated July 30, 2019, upon the reporting person's resignation as Chief Executive Officer, these RSUs automatically vested on January 8, 2020.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615937
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 6:14 PM ET
- Size
- 13.7 KB